Luminus Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Luminus Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,681,089	Closed	-$415K	–	37
2026 Q1	$415K	Buy	1,681,089 +522,328	+45%	+$208K	0.25%	20
2025 Q4	$487K	Buy	1,158,761 +908,761	+364%	+$482K	0.43%	15
2025 Q3	$168K	Buy	+250,000	New	+$135K	0.15%	19

Other funds holding SGMO

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

AIM

Axiom Investment Management New York $150M AUM

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Luminus Management's SGMO Position: Q2 2026 in Review

Luminus Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 1,681,089 shares — an estimated $415K sold.

Luminus Management first reported a position in SGMO in Q3 2025 and held it in 3 quarters. The position peaked at $487K in Q4 2025. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Luminus Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Luminus Management sold 1,681,089 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $415K.
Luminus Management first reported a position in SANGAMO THERAPEUTICS INC in Q3 2025 and held it in 3 quarters.
Luminus Management's SANGAMO THERAPEUTICS INC position peaked at $487K in Q4 2025.
6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Luminus Management's 13F filing for Q2 2026, filed 14 Aug 2026.